New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
16:13 EDTCVDCovance reports Q2 EPS 95c, consensus 93c
Reports Q2 revenue $639.35M, consensus $639.74M. The company said, "In the second quarter, a stronger-than-expected performance in Early Development and continued strong growth in central laboratories more than offset lower-than-expected growth in clinical development, leading to year-on-year revenue growth of 8%, expanded pro forma operating margins of 11.9%, and a 21.5% year-on-year increase in pro forma EPS. Commercial performance strengthened from the first quarter, with second quarter adjusted net orders of $773M resulting in an adjusted net book-to-bill of 1.21 to 1."
News For CVD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2015
20:22 EDTCVDA small miss for LabCorp could cause a share drop, Barron's says
Subscribe for More Information
January 23, 2015
07:32 EDTCVDCharles River Labs upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Charles River Labs (CRL) to Outperform citing improving demand for early-stage development services as well as opportunity for share gains due to Covance’s (CVD) pending merger with LabCorp (LH).
January 12, 2015
08:30 EDTCVDLabCorp upgraded to Outperform at RW Baird
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use